Open access
Oct 2026
Remdesivir use in hospitalized children with COVID-19: hepatic and systemic safety
Safety data regarding remdesivir in pediatric populations remain limited, particularly for those with complex comorbidities. This study evaluated the hepatic and systemic safety of remdesivir in hospitalized children with COVID-19 by comparing treated patients to a control group receiving no antiviral therapy....
Patrycja Puciato, K. Sequeira, В. В. Вартанян et al.
· Pediatria Polska · 0 citations